Effect of CD4+CD25+ and CD4+CD25- T regulatory cells on the generation of cytolytic T cell response to a self but human tumor-associated epitope in vitro
- PMID: 16393984
- DOI: 10.4049/jimmunol.176.2.984
Effect of CD4+CD25+ and CD4+CD25- T regulatory cells on the generation of cytolytic T cell response to a self but human tumor-associated epitope in vitro
Abstract
CD4+ T cells naturally expressing CD25 molecules (natural T regulatory cells (Tregs)) have a role in maintaining self tolerance and in regulating responses to infectious agents, transplantation Ags, and tumor Ags. CD4+ Tregs induced from CD4+CD25- precursors (induced Tregs) also regulate immune responses in the periphery. However, which of these Tregs is a major impediment in generating antitumor CTL responses is not clear. We show that although the CD4+CD25+ subsets isolated from peripheral blood-derived lymphocytes do suppress the proliferation of CD4+CD25- effector T cells, they do not suppress the activation and expansion of the self but melanoma-associated, melanoma Ag-reactive T cell 1 (MART-1)27-35-specific CD8+ T cells stimulated by the respective peptide-loaded matured dendritic cells in vitro. The CD4+CD25- counterparts, in contrast, lead to the generation of CD25+ glucocorticoid-inducible TNFR+-Forkhead/winged helix transcription factor+ populations and efficiently suppress the activation and expansion of the MART-127-35 epitope-specific CTLs. Our data suggest that when CTL precursors are optimally stimulated, natural Tregs are not a formidable constraint toward generating a robust antitumor CTL response, but induced Tregs could be.
Similar articles
-
The IL-4 receptor alpha-chain-binding cytokines, IL-4 and IL-13, induce forkhead box P3-expressing CD25+CD4+ regulatory T cells from CD25-CD4+ precursors.J Immunol. 2005 Nov 1;175(9):6107-16. doi: 10.4049/jimmunol.175.9.6107. J Immunol. 2005. PMID: 16237107
-
Suppression of inducible CD4 regulatory cells by MHC class I-restricted human tumor epitope specific TCR engineered multifunctional CD4 T cells.Hum Immunol. 2016 Oct;77(10):905-911. doi: 10.1016/j.humimm.2016.06.011. Epub 2016 Jun 16. Hum Immunol. 2016. PMID: 27320826
-
IFN-gamma controls the generation/activation of CD4+ CD25+ regulatory T cells in antitumor immune response.J Immunol. 2005 Oct 1;175(7):4433-40. doi: 10.4049/jimmunol.175.7.4433. J Immunol. 2005. PMID: 16177085
-
Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity.Immunol Rev. 2006 Aug;212:314-29. doi: 10.1111/j.0105-2896.2006.00422.x. Immunol Rev. 2006. PMID: 16903923 Review.
-
Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease.Immunol Rev. 2006 Aug;212:8-27. doi: 10.1111/j.0105-2896.2006.00427.x. Immunol Rev. 2006. PMID: 16903903 Review.
Cited by
-
CD4+ T-cell recognition of human 5T4 oncofoetal antigen: implications for initial depletion of CD25+ T cells.Cancer Immunol Immunother. 2008 Jun;57(6):833-47. doi: 10.1007/s00262-007-0419-8. Epub 2007 Nov 15. Cancer Immunol Immunother. 2008. PMID: 18004564 Free PMC article.
-
Regulatory T Cells, a Potent Immunoregulatory Target for CAM Researchers: Modulating Allergic and Infectious Disease Pathology (II).Evid Based Complement Alternat Med. 2006 Jun;3(2):209-15. doi: 10.1093/ecam/nel020. Epub 2006 Apr 19. Evid Based Complement Alternat Med. 2006. PMID: 16786050 Free PMC article.
-
Antitumor and Immunomodulatory Properties of the Bulgarian Endemic Plant Betonica bulgarica Degen et Neič. (Lamiaceae).Plants (Basel). 2022 Jun 26;11(13):1689. doi: 10.3390/plants11131689. Plants (Basel). 2022. PMID: 35807641 Free PMC article.
-
Standardized astragalus extract for attenuation of the immunosuppression induced by strenuous physical exercise: randomized controlled trial.J Int Soc Sports Nutr. 2021 Jul 16;18(1):57. doi: 10.1186/s12970-021-00425-5. J Int Soc Sports Nutr. 2021. PMID: 34271953 Free PMC article. Clinical Trial.
-
Tumor-released survivin induces a type-2 t cell response and decreases cytotoxic T cell function, in vitro.Cancer Microenviron. 2013 Apr;6(1):57-68. doi: 10.1007/s12307-012-0096-9. Epub 2012 Feb 10. Cancer Microenviron. 2013. PMID: 22322461 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials